Hilar cholangiocarcinoma: A review and commentary

Annals of Surgical Oncology

Volumn 7, Issue 1, 2000, Pages 55-66

  Chamberlain, Ronald S ^a   Blumgart, Leslie H ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bile duct cancer; Hilar cholangiocarcinoma; Surgery

Indexed keywords

BILIRUBIN; CARBOPLATIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; HEMATOPORPHYRIN DERIVATIVE; LOMUSTINE; METHOTREXATE; MITOMYCIN C; STREPTOZOCIN;

ARTERIOGRAPHY; BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; CHOLANGIOGRAPHY; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; HUMAN; LIVER TRANSPLANTATION; PARTIAL HEPATECTOMY; PATIENT SELECTION; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PHOTODYNAMIC THERAPY; PORTAL PHLEBOGRAPHY; PROGNOSIS; REVIEW; RISK FACTOR; SURGICAL APPROACH;

EID: 0033965084     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0055-4     Document Type: Review

References (65)

1. Kirschbaum JD, Kozoll DC. Carcinoma of the gall bladder and extrahepatic bile ducts. SGO 1941;73:740-53.
2. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995;75:171-90.
3. Nakeeb A, Pitt HA, Sohn TA, Coleman J, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463-75.
4. Tompkins RK, Thomas D, Wile A, et al. Prognostic factors in bile duct carcinoma. Ann Surg 1981;194:447-55.
5. Reding R, Buard JL, Lebeau G, Launois B. Surgical management of 552 carcinomas of the bile duct (gall bladder and periampullary excluded). Ann Surg 1991;213:236-41.
6. Pitt HA, Dooley WC, Yeo CJ, Cameron JL. Malignancies of the biliary tree. Curr Prob Surg 1995;32:1-90.
7. Thuluvath PJ, Rai R, Vembrux AC, Yeo CJ. Cholangiocarcinoma: a review. Gastroenterologist 1997;5:306-15.
8. Blumgart LH, Benjamin IS. Cancer of the bile ducts. In: Blumgart LH, ed. Surgery of the Liver and Biliary Tract. 2nd ed. London: Churchill Livingstone, 1994:1051-67.
9. Hadjis NS. Blenkharn JI, Alexander N, Benjamin IS, Blumgart LH. Outcome of radical surgery in hilar cholangiocarcinoma. Surgery 1990;107:597-604.
10. Burke E, Jarnigan WR, Hochwald SN, Pisters PWT, Fong Y, Blumgart LH. Hilar cholangiocarcinoma patterns of spread, the importance of hepatic resection for curative operation, and a pre-surgical clinical staging system. Ann Surg 1998;228:385-94.
11. Hochwald SN, Burke E, Jarnigan WR, Fong Y, Blumgart LH. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 1999;134:251-66.
12. Jarnigan WR, Burke E, Power C, Fong Y, Blumgart LH. Intrahepatic biliary enteric bypass provides effective palliation in selected patient with malignant obstruction at the hepatic duct confluence. Am J Surg 1998;175:453-60.
13. Karsten TM, Allema JH, Reinders M, et al. Preoperative biliary drainage, colonisation of bile and postoperative complications in patients with tumours of the pancreatic head: a retrospective analysis of 241 consecutive patients. Eur J Surg 1996;162:881-8.
14. McPherson GA, Benjamin IS, Hodgson HJ, Bowley NB, Allison DJ, Blumgart LH. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 1984;71:371-5.
15. Temudon T, Sarr MG, Douglas MG, Farnell MB. An argument against the routine percutaneous biopsy, ERCP, or biliary stent placement in patients with clinically resectable periampullary masses: a surgical perspective. Pancreas 1995;11:283-8.
16. Heslin MJ, Brooks AD, Hochwald SN, Blumgart LH, Brennan MF. A preoperative biliary stent is associated with increased complications after pancreaticoduodenectomy. Arch Surg 1998; 133:149-54.
17. Valek V, Ruzicka M. Preoperative drainage of the biliary tract in patients with obstructive jaundice. Rozhl Chir 1995;74:235-8.
18. Elyaderani MK, McDowell DE, Zimmermann B. Percutaneous transhepatic catheterization in reconstructive surgery of the biliary ducts. South Med J 1985;78:142-9.
19. Shaked A, Colonna JO, Goldstein L, Busuttil RW. The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg 1992;215:598-605.
20. Sako K, Seitzinger GL, Garside E. Carcinoma of the extra-hepatic bile ducts: review of the literature and report of six cases. Surgery 1957;41:416-37.
21. Kuwayti K, Baggenstoss AH, Stauffer MH, Preistley JI. Carcinoma of the major intrahepatic and extrahepatic bile ducts exclusive of the papilla of Vater. SGO 1957;104:357-66.
22. Weinbren K, Mutumm SS. Pathological aspects of cholangiocarcinoma. J Pathol 1983;139:217-38.
23. Shimada H, Nimoto S, Matsuba A, et al. The infiltration of the bile duct carcinoma along the bile duct wall. Int Surg 1988;73:87-90.
24. Skamoto E, Nimura Y, Hayakawa N, et al. The pattern of infiltration at the proximal border of hilar bile duct cancer: a histological analysis of 62 resected cases. Ann Surg 1998;227:405-11.
25. Gertsch P, Thomas P, Baer H, Lerut J, Zimmermann A, Blumgart LH. Multiple tumors of the biliary tract. Am J Surg 1990;159: 386-8.
26. Stain SC, Baer HU, Dennison AR, Blumgart LH. Current management of hilar cholangiocarcinoma. SGO 1992;175:579-88.
27. Hann LE. Fong Y, Shriver CD, et al. Malignant hepatic hilar tumors: can ultrasonography be used as an alternative to angiography with CT arterial portography for determination of resectability? J Ultrasound Med 1996;15:37-45.
28. Schwartz LH, Coakley FV, Sun Y, Blumgart LH, Fong Y, Panicek DM. Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography. AJR Am J Roentgenol 1998;170:1491-5.
29. Guthrie JA, Ward J, Robinson PJ. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging. Radiology 1996;201:347-51.
30. Lee MG, Lee HJ, Kim MH, et al. Extrahepatic biliary disease: 3D MR cholangiopancreatography. Radiology 1997;202:663-9.
31. Wetter LA, Ring EJ, Pellegrini CA, Way LW. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg 1991;161:57-62.
32. Ryan ME. Cytologic brushings of ductal lesions during ERCP. Gastrointest Endosc 1991;37:139-42.
33. American Joint Committee on Cancer, eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven, 1997.
34. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. SGO 1975;140:170-8.
35. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31-8.
36. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the extrahepatic bile ducts: histologic types, stage of disease, grade, and survival. Cancer 1992;70:1498-501.
37. Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer: a single-center experience. Ann Surg 1996;224:628-38.
38. Chamberlain RS, Blumgart LH. The surgical approach to cholangiocarcinoma. Curr Med Lit Gastroenterol 1999;18:24-40.
39. Tsuzuki T, Ueda M, Kuramochi S, et al. Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long-term survival. Surgery 1990;108:495-501.
40. Baer HU, Stain S, Dennison AR, Eggers B, Blumgart LH. Improvements in survival by aggressive resection in hilar cholangiocarcinoma. Ann Surg 1993;217:20-7.
41. Nagorney DM, Donohue JH, Farnell M, Sckleck LD, Ilstrup DM. Outcomes after curative resection of cholangiocarcinoma. Arch Surg 1993;128:871-9.
42. Suigura Y, Nakamura S, Iida S, et al. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 1994;115:445-51.
43. Su C-H, Tsay S-H, Wu C-C, et al. Factors influencing postoperative morbidity, mortality, and survival after liver resection for hilar cholangiocarcinoma. Ann Surg 1996;223:384-94.
44. Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998;227:70-9.
45. Figueras J, Llado-Garriga L, Lama C, et al. Resection as elective treatment of hilar cholangiocarcinoma. Gastroenterol Hepatol 1998;21:218-23.
46. Nagino M, Nimura Y, Kamiya J, et al. Segmental liver resection for hilar cholangiocarcinoma. Hepatogastroenterology 1998;45:7-13.
47. Miyazaki M, Ito H, Nakagawa K, et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 1998;123:131-6.
48. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 1990;14:535-44.
49. Ringe B, Witteking C, Bechstein WO, Buzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancies: a retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1988;209:88-98.
50. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997;79:26-34.
51. Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998;187:358-64.
52. Jeyarajah DR, Klintmalm GB. Is liver transplantation indicated for cholangiocarcinoma? J Hepatobil Pancreat Surg 1998;5:48-51.
53. Shapiro MJ. Management of malignant biliary obstruction: nonoperative and palliative techniques. Oncology 1995;9:493-6.
54. Schmassmann A, von Guten E, Knuchel J, Scheurer U, Fehr HF, Halter F. Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol 1996;91: 654-9.
55. Pack BT, Islami AH. Tumors of the Liver. Berlin: Springer-Verlag, 1970.
56. Kuvshinoff BW, Armstrong JG, Fong Y, et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 1995;82:1522-55.
57. Leung JT, Kuan R. Intraluminal brachytherapy in the treatment of bile duct carcinomas. Australas Radiol 1997;41:151-4.
58. Vallis KA, Benjamin IS, Munro AJ, et al. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability. Radiother Oncol 1996;41:61-6.
59. McMasters KM, Tuttle TM., Leach SD, et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 1997; 174:605-9.
60. Hishinuma S, Ogata Y, Matsui J, Ozawa I, Imura J. Preoperative radiotherapy for cancer of the extrahepatic bile duct. Am J Clin Oncol 1998;21:203-8.
61. Sanz-Altamira PM, Ferrante K, Jenkins RL, Lewis WD, Huberman MS, Stuart KE. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer 1998;82:2321-5.
62. Patt YZ, Jones DV, Hoque A, et al. Phase II trial of intravenous fluorouracil and subcutaneous interferon alpha-2b for biliary tract cancer. J Clin Oncol 1996;14:2311-5.
63. Ravry MJ, Omura GA, Bartolucci AA, Einhorn L, Kramer C, Davila E. Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southeastern Cancer Study Group Trial. Cancer Treat Res 1986;70:311-2.
64. Bukowski RM, Leichman LP, Rivkin SE. Phase II trial of m-AMSA in gallbladder and cholangiocarcinoma: a Southwest Oncology Group Study. Eur J Cancer Clin Oncol 1983;19:721-3.
65. Ortner MA, Liebetruth J, Schreiber S, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998;114: 536-42.